Basic and Clinical Andrology,
Год журнала:
2023,
Номер
33(1)
Опубликована: Апрель 5, 2023
Erectile
function
depends
on
a
complex
interaction
between
demographic,
metabolic,
vascular,
hormonal,
and
psychological
factors
that
trigger
erectile
dysfunction
(ED).
In
the
present
study
we
carried
out
cross-sectional
assessing
impact
of
non-communicable
chronic
diseases
(NCDs),
male
hypogonadism,
demographic
in
characterizing
men
with
ED.
Four
hundred
thirty-three
consecutive
outpatients
ED
were
extracted
from
electronic
database
January
2017
to
December
2019.
The
International
Index
Function
(IIEF)
5
score
was
used
diagnose
stratify
its
severity,
standardized
values
serum
testosterone
(10.5
nM/L)
luteinizing
hormone
(LH
9.4
IU/L)
classify
hypogonadism
Charlson
Comorbidity
(CCI)
weigh
role
each
NCD
Diabetes/Metabolism Research and Reviews,
Год журнала:
2021,
Номер
38(2)
Опубликована: Сен. 13, 2021
Diabetes
mellitus
(DM),
a
chronic
metabolic
disease
characterised
by
elevated
levels
of
blood
glucose,
is
among
the
most
common
diseases.
The
incidence
and
prevalence
DM
have
been
increasing
over
years.
complications
represent
serious
health
problem.
long-term
include
macroangiopathy,
microangiopathy
neuropathy
as
well
sexual
dysfunction
(SD)
in
both
men
women.
Erectile
(ED)
has
considered
important
SD
with
DM.
ED
approximately
3.5-fold
higher
than
those
without
Common
risk
factors
for
development
its
sedentary
lifestyle,
overweight/obesity
increased
caloric
consumption.
Although
lifestyle
changes
may
help
improve
function,
specific
treatments
are
often
needed.
This
study
aims
to
review
definition
DM,
impact
treatment
on
and,
finally,
current
emerging
therapies
patients
Frontiers in Endocrinology,
Год журнала:
2023,
Номер
14
Опубликована: Апрель 25, 2023
The
purpose
of
this
study
is
to
examine
the
association
between
a
novel
adiposity
parameter,
weight-adjusted-waist
index
(WWI),
and
erectile
dysfunction
(ED).According
National
Health
Nutrition
Examination
Survey
(NHANES)
2001-2004,
total
3884
participants
were
categorized
as
ED
non-ED
individuals.
WWI
was
calculated
waist
circumference
(WC,
cm)
divided
by
square
root
weight
(kg).
Weighted
univariable
multivariable
logistic
regression
models
conducted
assess
correlation
ED.
Smooth
curve
fitting
utilized
linear
association.
receiver
operating
characteristic
(ROC)
DeLong
et
al.'s
test
applied
compare
area
under
(AUC)
value
predictive
power
among
WWI,
body
mass
(BMI),
WC
for
ED.WWI
positively
related
with
full
adjustment
[odds
ratio
(OR)=1.75,
95%
confidence
interval
(95%
CI):
1.32-2.32,
p=0.002].
After
converting
categorical
variable
quartiles
(Q1-Q4),
compared
Q1
highest
quartile
linked
an
obviously
increased
likelihood
(OR=2.78,
CI:
1.39-5.59.
p=0.010).
Subgroup
analysis
revealed
stability
independent
positive
relationship
It
shown
that
had
stronger
prediction
(AUC=0.745)
than
BMI
(AUC=0.528)
(AUC=0.609).
Sensitivity
performed
verify
significantly
connection
stricter
(OR=2.00,
1.36-2.94,
p=0.003).An
elevated
higher
risks
in
United
State
adults,
observed
WC.
Andrology,
Год журнала:
2022,
Номер
11(2), С. 257 - 269
Опубликована: Авг. 5, 2022
Erectile
dysfunction
is
associated
with
diabetes
mellitus
an
estimated
prevalence
of
52.5%
in
the
diabetic
population.
The
first-line
therapy
for
erectile
phosphodiesterase
type
5
inhibitors,
but
data
suggest
that
men
may
be
less
responsive
than
non-diabetic
men.
Thus,
other
treatments,
including
intracavernosal
injections,
intraurethral
prostaglandin,
vacuum
erection
devices
and
penile
prosthetic
surgery,
should
considered
management
refractory
to
inhibitors.
Furthermore,
combination
inhibitors
oral
treatments
such
as
arginine
or
l-carnitine
have
synergistic
effects
resulting
better
outcomes.
In
addition,
there
are
novel
therapies
low-intensity
shockwave
stem-cell
therapy,
which
also
effective
targeted
treatment
modalities.
studies
can
improved
by
targeting
concurrent
comorbidities
metabolic
diseases
depression,
hypertension,
hypogonadism,
dyslipidaemia.
We
present
evidence-based
narrative
review
focusing
on
who
not
responded
inhibitors.Both
clinicians
patients
aware
different
options
Frontiers in Endocrinology,
Год журнала:
2023,
Номер
14
Опубликована: Март 30, 2023
Abnormal
body
mass
index
(BMI)
is
associated
with
an
increased
risk
of
erectile
dysfunction
(ED).
However,
the
relationship
between
different
BMI
categories
and
levels
ED
severity
remains
unclear.
In
current
study,
878
men
from
andrology
clinic
in
Central
China
were
recruited.
Erectile
function
was
assessed
by
International
Index
Function
(IIEF)
scores.
Questionnaires
included
questions
about
demographic
characteristics
(age,
height,
weight,
educational
status),
lifestyle
habits
(drinking,
smoking,
sleep
time),
medical
history.
Logistic
regression
used
to
examine
association
BMI.
The
incidence
53.1%.
significantly
higher
group
than
those
non-ED
(
P
=
0.01).
Compared
normal
weight
group,
obese
had
a
(OR
1.97,
95%
CI
1.25-3.14,
0.004),
even
after
adjustment
for
potential
confounders
1.78,
1.10-2.90,
0.02).
Moreover,
positive
correlation
obesity
moderate/severe
confirmed
logistic
analysis
(moderate/severe
ED,
OR
2.71,
1.44-5.04,
0.002),
adjusting
2.51
1.24-5.09,
Collectively,
our
findings
indicate
ED.
Clinicians
could
pay
more
attention
patients
maintain
healthy
improve
function.
Lipids in Health and Disease,
Год журнала:
2024,
Номер
23(1)
Опубликована: Май 13, 2024
Abstract
Introduction
Although
previous
studies
have
linked
obesity
and
erectile
dysfunction,
the
novel
surrogate
indicators
of
adipose
accumulation
are
more
essential
dependable
factors
to
consider.
Therefore,
primary
objective
current
investigation
was
examine
clarify
association
between
metabolic
score
for
visceral
fat
(METS-VF)
dysfunction.
Methods
Firstly,
multivariate
logistic
regression
analysis,
smoothed
curve
fitting,
threshold
effect
analysis
were
employed
investigate
METS-VF
Mediation
also
performed
evaluate
mediating
role
homocysteine
inflammation.
After
that,
subgroup
carried
out
stability
correlation
with
dysfunction
in
various
population
settings.
Furthermore,
area
under
receiver
operating
characteristic
(ROC)
eXtreme
Gradient
Boosting
(XGBoost)
algorithm
utilized
assess
capability
identifying
comparison
other
four
obesity-related
Results
adjusting
all
confounding
factors,
strongly
favourablely
correlated
With
each
additional
unit
rise
METS-VF,
prevalence
increased
by
141%.
A
J-shaped
relationship
discovered
through
fitting.
Marital
status,
physical
activity,
smoking
status
can
potentially
modify
this
association.
This
finding
ROC
suggests
that
had
a
powerful
capacity
(AUC
=
0.7351).
Homocysteine
inflammation
mediated
4.24%
2.81%,
respectively.
Conclusion
The
findings
suggest
be
considered
indicator
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(7), С. 2087 - 2087
Опубликована: Апрель 3, 2024
Background:
This
cross-sectional
study
aimed
to
investigate
the
prevalence
of
erectile
dysfunction
(ED)
in
elderly
men
with
overweight
or
obesity
and
coronary
artery
disease.
Methods:
Patients
recruited
cardiac
rehabilitation
centers
post-myocardial
infarction
provided
demographic
anthropomorphic
data.
ED
was
assessed
using
abbreviated
International
Index
Erectile
Function
5
(IIEF-5)
Questionnaire.
Results:
The
included
661
a
mean
age
67.3
±
5.57
years,
BMI
27.9
3.6
m/kg2,
waist
circumference
98.9
10.23
cm.
Over
90%
experienced
ED,
similar
proportions
across
categories.
development
≥100
cm
had
3.74
times
higher
odds
(OR
3.74;
95%
CI:
1.0-13.7;
p
=
0.04)
than
<100
Men
moderate-to-severe
severe
were
older
compared
those
without
these
disorders
(67.1
5.29
vs.
65.3
4.35;
0.23).
Conclusions:
disease
surpasses
90%.
An
increased
body
weight
raises
risk
proving
be
more
reliable
predictor
this
BMI.
Physicians
are
encouraged
screen
patients
cardiovascular
for
address
enhance
overall
health.
Abstract
Background
Erectile
dysfunction
is
no
longer
a
whisper
in
the
shadows;
it’s
rising
tide
threatening
sexual
health
of
millions
men
different
regions.
In
cases
diabetes,
condition
worsens
and
has
potent
cocktail
physical
psychological
distress,
chipping
away
at
men’s
confidence,
self-esteem,
mental
health.
This
worrying
trend
shows
signs
slowing
down,
with
projections
claiming
staggering
322
million
globally
could
be
affected
near
future.
urgent
issue
demands
immediate
attention
action.
Thus,
this
umbrella
review
intended
to
estimate
current
burden
erectile
associated
risk
factors
among
diabetic
patients
global
context.
Methods
Following
PRISMA
guidelines,
we
searched
for
relevant
studies
PubMed,
Embase,
Scopus,
Web
Science,
Cochrane
Database
Systematic
Reviews,
Google
Scholar.
These
reported
prevalence
patients.
The
quality
included
was
assessed
using
Assessment
Multiple
Reviews
2
tool.
To
pooled
dysfunction,
employed
weighted
inverse
variance
random-effects
model.
We
further
conducted
subgroup
analyses,
heterogeneity
publication
bias,
performed
sensitivity
analyses
strengthen
robustness
our
findings.
Prediction
intervals
were
also
calculated
range
within
which
future
observations
will
likely
fall.
all
statistical
significance
declared
P-
value
<
0.05.
Results
review,
total
108
030
male
dysfunction.
65.8%
(95CI:
58.3
−
73.3%),
while
Africa
it
62.9%
46.1–79.7).
Age
(>
40
years)
(AOR
=
1.95,
95CI:
1.03–3.24),
DM
duration
10years)
1.90,95CI:
1.16–2.65),
peripheral
vascular
disease
2.74,
1.42–4.06)
BMI
30
kg/m2)
1.07,95CI:
1.01–1.20)
identified
as
patient.
Conclusion
high
(ED)
alarming,
an
estimated
two-thirds
experiencing
condition.
findings
underscore
significant
ED
faced
by
emphasize
need
issue.
includes
promoting
early
screening
population
ensuring
access
appropriate
treatment
support.
Materials Today Bio,
Год журнала:
2023,
Номер
19, С. 100588 - 100588
Опубликована: Фев. 20, 2023
Organic
erectile
dysfunction
(ED)
is
a
type
of
sexual
disorder
in
men
that
usually
associated
with
illness,
surgical
injury,
normal
aging
and
has
high
incidence
across
the
globe.
And
essence
penile
erection
neurovascular
event
regulated
by
combination
factors.
Nerve
vascular
injury
are
main
causes
dysfunction.
Currently,
treatment
options
for
ED
include
phosphodiesterase
5
inhibitors
(PDE5Is),
intracorporeal
injections
vacuum
devices
(VEDs),
which
ineffective.
Therefore,
it
essential
to
find
an
emerging,
non-invasive
effective
ED.
The
histopathological
damage
causing
can
be
improved
or
even
reversed
hydrogels,
contrast
current
therapies.
Hydrogels
have
many
advantages,
they
synthesized
from
various
raw
materials
different
properties,
possess
definite
composition,
good
biocompatibility
biodegradability.
These
advantages
make
hydrogels
drug
carrier.
In
this
review,
we
began
overview
underlying
mechanisms
organic
dysfunction,
discussed
dilemmas
existing
treatments
ED,
described
unique
hydrogel
over
other
approaches.
Then
emphasizing
progress
research
on